Johnson & Johnson (JNJ)
234.18
-0.36
(-0.15%)
USD |
NYSE |
Apr 17, 16:00
233.90
-0.28
(-0.12%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly) : 2.141 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 1.742 |
| Protagonist Therapeutics, Inc. | -0.6932 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.235B |
| Revenue (Quarterly) | 24.06B |
| Total Expenses (Quarterly) | 18.83B |
| Enterprise Value | 593.28B |
| Gross Profit Margin (Quarterly) | 71.49% |
| Profit Margin (Quarterly) | 21.76% |
| Earnings Yield | 3.69% |
| Operating Earnings Yield | 4.52% |
| Normalized Earnings Yield | 3.888 |